Use of nasal potential difference and sweat chloride as outcome measures in multicenter clinical trials in subjects with cystic fibrosis.

Ahrens, Richard C; Standaert, Thomas A; Launspach, Janice; Han, Seung-Ho; Teresi, Mary E; Aitken, Moira L; Kelley, Thomas J; Hilliard, Kathleen A; Milgram, Laura J H; Konstan, Michael W; Weatherly, Mark R; McCarty, Nael A

Ahrens, Richard C; Standaert, Thomas A; Launspach, Janice; Han, Seung-Ho; Teresi, Mary E; Aitken, Moira L; Kelley, Thomas J; Hilliard, Kathleen A; Milgram, Laura J H; Konstan, Michael W; Weatherly, Mark R; McCarty, Nael A.

Affiliation

Ahrens RC; Department of Pediatrics, University of Iowa, Iowa City, Iowa 52242-1083, USA. richard-ahrens@uiowa.edu

Pediatr Pulmonol ; 33(2): 142-50, 2002 Feb.

Article in En | MEDLINE | ID: mdl-11802252

Subject(s)

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Sweat / Chlorides / Cystic Fibrosis / Nasal Mucosa Type of study: Clinical_trials / Guideline / Prognostic_studies Limits: Adolescent / Adult / Female / Humans / Male Language: En Journal: Pediatr Pulmonol Journal subject: PEDIATRIA Year: 2002 Document type: Article Affiliation country: Estados Unidos

Search on Google

Add to My VHL

XML

PubMed Links